References
- Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Fuhner P. Colo-rectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 1979; 5: 957–972
- Del Villano B C, Brennan S, Brock P, et al. Radio-immunometric assay for an antibody-defined tumor marker, CA19–9. Clin Chem 1983; 29: 549–552
- Lindholm L, Holmgren J, Svennerholm L, et al. Monoclonal antibodies against gastrointestinal tumor-associated antigens isolated as monosialogan-gliosides. Int Arch Allergy Appl Immunol 1983; 71: 178–181
- Holmgren J, Lindholm L, Persson B, et al. Detection by monoclonal antibody of carbohydrate antigen CA-50 in serum of patients with carcinoma. Br Med J 1984; 288: 1479–1482
- Chung Y S, Ho J J L, Kim Y S, et al. The detection of human pancreatic cancer-associated antigen in the serum of cancer patients. Cancer 1987; 60: 1636–1643
- Metzgar R A, Gaillard M T, Levine S T, Tuck F L, Bossen E H, Borowitz M J. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 1982; 2: 601–608
- Metzgar R A, Rodriguez N, Finn O J, Sandier R S, Seigler H F. Detection of a pancreatic cancer associated antigen (Du-Pan 2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci 1984; 81: 5242–5246
- Fukushi Y, Nudelman E, Levery S B, Hakomori S, Rauvala H. Novel fucolipids accumulating in human adenocarcinoma. I. I. I. A hybridoma antibody (FH6) defining a human cancer-associated difucogan-glioside (VI3NeuAcV3III3Fuc2-nLc6). J Biol Chem 1984; 259: 10511–10517
- Kannagi R, Fukushi Y, Tachikawa T, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialylfucosyl type 2 chain poly-lactosamine. Cancer Res 1986; 46: 2619–2626
- Magnani J L, Steplewski Z, Koprowski H, Ginsburg V. Identification of gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19–9 in the sera of patients as a mucin. Cancer Res 1983; 43: 5489–5492
- Kalthoff H, Kreiker C, Schmiegel W H, Greten H, Thiele H G. Characterization of CA19–9 bearing mucins as physiological exocrine pancreatic secretion products. Cancer Res 1986; 46: 3605–3607
- Klug T L, LeDonne N C, Greber T F, Zurawski V R, Jr. Purification and comparison of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lact-N-fucopentaose II(CA19–9). Cancer Res 1988; 48: 1505–1511
- Lan M S, Khorrami A, Kaufman B, Metzgar R S. Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. J Biol Chem 1987; 262: 12863–12870
- Ho J J L, Chung Y S, Fujimoto Y, et al. Mucin-like antigens in a pancreatic cancer cell line identified by murine monoclonal antibodies SPan-1 and YPan-1. Cancer Res 1988; 48: 3924–3931
- Singhal A K, Orntoft T F, Nudelman E, et al. Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 1990; 50: 1375–1380
- Ligtenbeg M J L, Vos H L, Gennissen A M C, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino acid. J Biol Chem 1990; 265: 5573–5578
- Lan M S, Batra S K, Qi W N, Metzger R S, Hol-Lingsworth M A. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem, 265: 15294–15299
- Gendler S J, Lancaster C A, Papadimitriou J T, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286–15293
- Hashida S, Imagawa M, Inoue S, Ruan K H, Ishi-Kawa E. More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through thiol groups in the hinge. J Appl Biochem 1984; 6: 56–63
- Avrameas S, Ternynck T. Coupling of glutar-aldehyde treated peroxidase with antibody or Fab. Immunochemistry 1971; 8: 1175–1179
- Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci 1979; 76: 4350–4354
- Ching C K, Rhodes J M. Identification and partial characterization of a new pancreatic cancer-related serum glycoprotein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and lectin blotting. Gastroenterology 1988; 95: 137–142
- Ching C K, Rhodes J M. Enzyme-linked PNA lectin binding assay compared with CA19–9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. Br J Cancer 1989; 59: 949–953
- Haga Y, Horiuchi S, Morino Y, Akagi M. Partial purification and characterization of CA19–9 antigen from the ascitic fluid of a patient with pancreatic cancer. Clin Biochem 1989; 22: 363–368